Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $272.6M | $310.6M | $302.5M | $363.1M | $437.1M | $510.8M | $590.6M | $688.1M |
| Cost of revenue | $68.6M | $86.9M | $88.2M | $101.9M | $131.9M | $162.9M | $191.1M | $246.8M |
| Gross profit | $204.0M | $223.7M | $214.3M | $261.2M | $305.3M | $347.8M | $399.4M | $441.3M |
| Gross margin | 74.8% | 72.0% | 70.8% | 71.9% | 69.8% | 68.1% | 67.6% | 64.1% |
| R&D | $3.9M | $7.6M | $6.8M | $11.3M | $16.2M | $20.3M | $21.4M | $13.0M |
| Operating income | $61.5M | $40.1M | $49.4M | $58.8M | $61.5M | $74.4M | $90.8M | $115.6M |
| EBITDA | $85.0M | $73.8M | $82.0M | $97.8M | $107.0M | $119.6M | $160.5M | $190.5M |
| Net income | $45.8M | $11.9M | $37.1M | $51.5M | $46.2M | $47.4M | $72.9M | $96.1M |
| Net margin | 16.8% | 3.8% | 12.3% | 14.2% | 10.6% | 9.3% | 12.3% | 14.0% |
| EPS (diluted) | 2.29 | 0.59 | 1.85 | 2.58 | 2.31 | 2.37 | 3.65 | 4.81 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $758M | $5.16 | $4.97–$5.30 | 1 |
| 2027 | $851M | $5.86 | $5.65–$6.02 | 1 |
| 2028 | $946M | $6.92 | $6.67–$7.11 | 1 |
| 2029 | $1.1B | $8.43 | $8.13–$8.67 | 1 |
Forward consensus · source: Financial Modeling Prep
MEDACTA GROUP SA
No one on the platform currently holds MEDGF.
No tracked institution reports a position in MEDGF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-08 | $1.1000 | 2026-05-11 |
| 2025-05-12 | $0.3450 | 2025-05-13 |
| 2025-05-09 | $0.3450 | 2025-05-13 |
| 2024-05-10 | $0.2750 | 2024-05-14 |
No one on the platform has traded MEDGF yet.
| $1.6B |
| — |
| PHMMFPharma Mar, S.A. | $79.49 | +0.00% | $1.4B | — |
| STSEYStratec SE | $5.51 | +0.00% | $1.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.